Anondita Medicare Lands International Order for Condom Supply Worth Rs 5.11 Crore
Anondita Medicare Limited has secured an additional purchase order from an international entity for the supply and delivery of male condoms, with the contract valued at approximately Rs 5.11 Crores (Rupees Five Crore Eleven Lakhs Only). This new agreement is set to be executed by July 31, 2026.The order was received via email dated June 23, 2026, from 1 Stop Medical Supplies, a company based in South Africa. The contract pertains specifically to the supply and delivery of male condoms to the international entity.
The transaction details regarding the order are summarized below:
| Key Aspect | Detail |
|---|---|
| Entity Awarding Order | 1 Stop Medical Supplies |
| Nature of Contract | International order for the supply and delivery of male condoms |
| Counterparty Status | International Entity |
| Type of Supply | Condom Supply |
| Execution Timeline | The order must be executed by July 31, 2026 |
| Order Size | Rs 5.11 crore (approx.) |
In addition to the international business secured, the company confirmed that there is no interest from the promoter group or affiliated entities in the entity awarding the contract, nor would the order fall within related party transactions.
ANONDITA Stock Price Movement
Today, Anondita Medicare Limited shares edged higher to close at ₹1192.35, gaining 1.86%. The stock saw total trading of 22,200 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.